University of California - Riverside

Biomedical technology

Candy-coated pills could prevent pharmaceutical fraud

While most of us were baking sourdough bread and watching "Tiger King" to stay sane during the pandemic shutdown, UC Riverside bioengineering professor William Grover kept busy counting the colorful candy sprinkles perched ...

Diseases, Conditions, Syndromes

Is there still a benefit to masking?

With California coronavirus cases rising—the state has recently been recording about 5,600 coronavirus cases a day—should you be masking up when people around you are not? Can you go unmasked everywhere? How best can ...

Health

Experts urge reconsideration of 'standard' for time-keeping

The U.S. Senate passed a bill on March 15 that would make daylight savings time permanent. It was approved by consent—and some are framing this procedural move as an "end run," as many senators said they were surprised ...

Vaccination

Q & A: Should you get a second booster shot for COVID-19?

The Biden administration is planning to give Americans age 50 or older the option of a second booster. But is a second booster necessary? Would it differ from the first booster? And who should receive the second booster first?

Medications

A potential antiviral for SARS and SARS-like coronaviruses

Both SARS-CoV-1, the virus that caused the 2003 outbreak of Severe Acute Respiratory Syndrome (SARS), and SARS-CoV-2, which causes COVID-19, originate from a group of betacoronaviruses known as "subgroup 2b." Coronaviruses ...

Diseases, Conditions, Syndromes

Researchers develop molecular traps to target SARS-CoV-2

A research team led by scientists at UC Riverside and UCLA has engineered novel nanoparticles to serve as "molecular traps" to target SARS-CoV-2, the virus that spreads COVID-19. The traps bind to SARS-CoV-2 and prevent it ...

page 7 from 34